Health Impact Assessment in the Business Process
Caterina Uberti‐Foppa(Vita-Salute San Raffaele University), Angelo Madera(Eni (Italy)), Guillermo Montoya Gómez(Eni (Italy))
SPE International Conference on Health, Safety and Environment in Oil and Gas Exploration and Production
April 15, 2008
Cited by 0
Related Papers
Human Papillomavirus Infection and Associated Cervical Disease in Human Immunodeficiency Virus–Infected Women: Effect of Highly Active Antiretroviral Therapy
|The Journal of Infectious Diseases|2001|173
Discontinuation of Secondary Prophylaxis against<i>Pneumocystis carinii</i>Pneumonia in Patients with HIV Infection Who Have a Response to Antiretroviral Therapy
|New England Journal of Medicine|2001|168
Safe Interruption of Maintenance Therapy against Previous Infection with Four Common HIV-Associated Opportunistic Pathogens during Potent Antiretroviral Therapy
|Annals of Internal Medicine|2002|136
Real-world effectiveness and safety of glecaprevir/pibrentasvir in 723 patients with chronic hepatitis C
|Journal of Hepatology|2018|133
Real-Time PCR Assay for Clinical Management of Human Immunodeficiency Virus-Infected Patients with Visceral Leishmaniasis
|Journal of Clinical Microbiology|2003|122